Gerresheimerwill acquire the Swiss technology company Sensile Medical and thereby significantly expand its business offerings. For the Sensile Medical business, this will open up new opportunities and synergies with existing and potential new customers. The combination of the two companies will also enable Gerresheimer to enhance its Drug Delivery offering for its Pharmaceutical and Biotech partners, especially with new digital and electronic capabilities.

As part of Gerresheimer, Sensile Medical is an integral part of this internationally focused company, with its strong orientation within Drug and Healthcare sectors in key markets around the world. The broad offering of products and solutions by Gerresheimer will create a range of synergies. Gerresheimer’s extensive range of primary packaging for parenterals will prove valuable in the development of device and delivery systems.

Synergies with Gerresheimer’s production and commercial manufacturing capabilities, especially in the MedicalPlastic Systemsbusiness unit, will allow us to provide complete solutions for our Partners in the future. Going forward, it is planned that Sensile Medical will function as the Development Center for Value Added Devices within the Gerresheimer Group.

Andreas Schütte, Executive Board Member, Gerresheimer AG Plastics & Devices:

“We will accelerate our growth and open new opportunities for business expansion. Sensile Medical is a perfect fit for us with its innovative products and platforms in drug delivery systems, including ‘connected’ devices.”

Derek Brandt, Sensile Medical CEO adds:

“This transactionrepresents a key Milestone in Sensile Medical’s growth strategy. Gerresheimeris an ideal partner for Sensile Medical in so many ways. We look forward to becoming part of Gerresheimer’s success in the future.”